Lamıya Alıyeva Javıt, MD

Lamıya Alıyeva Javıt, MD is a Medical Genetics specialist at Acibadem Altunizade Hospital in İstanbul, where she practices in the Medical Genetics Department. Her clinical work is centered on the evaluation of genetic conditions, structured genetic assessment and medical genetics consultation for patients referred with a suspected or known hereditary condition. She has more than 15 years of experience in medicine, spanning early clinical work in Bakü, academic training and specialist practice.

Dr. Javıt began her medical career as an assistant doctor at Kübra Ferecova Adına Elmi Tedqiqat Pediatriya Institutu in Bakü between 2011 and 2014, and graduated from Azerbaycan Tıp University Faculty of Medicine in 2014. She then undertook specialty training in Medical Genetics at Uludağ University Faculty of Medicine, working as a research assistant doctor in the Department of Medical Genetics from 2016 to 2020 and completing her training in 2020. She has been part of Acıbadem Healthcare Services since 2021.

Clinical focus

Dr. Javıt’s practice covers the assessment of genetic conditions and the provision of medical genetics consultation. A genetic assessment typically involves a detailed review of the patient’s personal and family medical history, evaluation of clinical findings and consideration of whether genetic testing may be informative. When testing has already been performed, results are interpreted in the context of the individual patient and discussed in clear terms, including what the findings may mean for the patient and, where relevant, for family members. Because genetic information can have long-term implications, consultations are conducted with a cautious, individualized approach, and the limits of what a test can and cannot show are explained.

Alongside her clinical work, Dr. Javıt has contributed to peer-reviewed research in medical genetics. She is a co-author of a study on BRCA variation risk assessment in breast cancers using different artificial intelligence models, published in Genes in 2021; a single-center analysis of the frequency and distribution of MEFV gene mutations in familial Mediterranean fever patients, published in Med J SDU / SDU Tıp Fak Derg in 2019; and a report on lysinuric protein intolerance and HOIP deficiency involving SLCA7A and RNF31 gene disruptions in a boy, published in Journal of Biotechnology in 2018.

How Dr. Javıt works with international patients

Dr. Javıt consults in Turkish and English, and interpreters can be arranged for patients who speak other languages. Before a visit, the Acibadem international patient team coordinates the collection of prior reports and imaging, such as laboratory and pathology results, previous genetic test reports, MRI, CT, X-ray or ultrasound reports, operative notes and discharge summaries, and arranges appointments and the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing results and previous treatments, a clinical examination and a discussion of the options. Video consultation is also available for international patients.